CureVac N.V. - Ordinary Shares (NQ:CVAC)

4.660 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CureVac N.V. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

BioNTech Navigates Post-Pandemic Deficit: A €17 Billion Bet on the Oncology Frontier

March 10, 2026

In a watershed moment for the biotechnology sector, BioNTech SE (NASDAQ: BNTX) has reported its full-year 2025 financial results, signaling the definitive end of the COVID-19 vaccine gold rush and the...

Via MarketMinute

BioNTech Finalizes CureVac Acquisition: A Strategic Consolidation Met with Market Skepticism

January 09, 2026

In a move that signals the end of an era for independent mRNA pioneers, BioNTech SE (Nasdaq: BNTX) has officially completed its acquisition of longtime rival CureVac N.V. (Nasdaq: CVAC). The...

Via MarketMinute

Topics Intellectual Property

CureVac Announces Voting Results of Extraordinary General Meeting

November 25, 2025

Via ACCESS Newswire

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates

November 24, 2025

Via ACCESS Newswire

CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates

August 15, 2025

Via ACCESS Newswire

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth ↗

August 04, 2025

BioNTech beat Q2 estimates with higher COVID vaccine revenue and reaffirmed 2025 guidance.

Via Benzinga

Cooling US Bird Flu Wave Removes Tailwind For Moderna, Novavax, CureVac, Traws Pharma ↗

July 08, 2025

The CDC reportedly deactivated its bird flu emergency response last week, folding surveillance into its regular flu tracking and ending animal infection updates.

Via Stocktwits

This Trade Desk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗

June 26, 2025

Via Benzinga

CureVac Announces Voting Results of General Meeting

June 24, 2025

Via ACCESS Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLP, VERV, CVAC on Behalf of Shareholders

June 20, 2025

From Halper Sadeh LLC

Via GlobeNewswire

5 Stocks To Ride The German Market Rally ↗

June 16, 2025

Via Benzinga

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVAC, KNW, SOAR, HLGN on Behalf of Shareholders

June 13, 2025

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CureVac N.V. (Nasdaq - CVAC), Know Labs, Inc. (NYSE American - KNW), Volato Group, Inc. (NYSE American - SOAR), Heliogen, Inc. (OTC - HLGN)

June 13, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

This Sherwin-Williams Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday ↗

June 13, 2025

Via Benzinga

Market Monitor News June 13 (Oracle UP - Gamestop DOWN) ↗

June 13, 2025

U.S. stocks edge higher as inflation cools, Oracle soars on AI growth, and markets brace for Israel-Iran conflict escalation.

Via Chartmill

Topics Artificial Intelligence Economy

Here are the top movers in Thursday's session. ↗

June 12, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Thursday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Let's take a look at the stocks that are in motion in today's session. ↗

June 12, 2025

Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Nasdaq Moves Higher; Oracle Shares Jump After Upbeat Q4 Results ↗

June 12, 2025

Via Benzinga

BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal ↗

June 12, 2025

BioNTech agreed to buy CureVac for $1.25 billion, expanding its mRNA cancer research and boosting its oncology pipeline.

Via Benzinga

CureVac, TELUS International, Oracle And Other Big Stocks Moving Higher On Thursday ↗

June 12, 2025

Via Benzinga

There are notable gap-ups and gap-downs in today's session. ↗

June 12, 2025

Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

BioNTech To Acquire CureVac In All-Stock Deal Valued At $1.25B: Retail Sees Breakthrough In Cancer Treatment ↗

June 12, 2025

Under the terms of the deal, each CureVac share will be exchanged for approximately $5.46 in BioNTech American depositary shares.

Via Stocktwits

CVAC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of CureVac N.V. Is Fair to Shareholders

June 12, 2025

From Halper Sadeh LLC

Via Business Wire

Wondering what's happening in today's pre-market session? ↗

June 12, 2025

Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.

Via Chartmill

Trump Administration Terminates $590 Million Moderna Bird Flu Vaccine Deal, Dismantling Biden-Era Pandemic Preparedness Effort ↗

May 29, 2025

The Trump administration terminated a nearly $600 million award to Moderna for developing an mRNA-based bird flu vaccine, ending a key Biden-era pandemic preparedness initiative. The cancellation...

Via Benzinga

Topics Government

CureVac (CVAC) Stock Rises After Q1 Update, Oncology Pipeline Gains Traction ↗

May 20, 2025

CureVac stock surged after reporting Q1 2025 results and a positive pipeline update. The biotech firm narrowed its operating loss, and cash is expected to fund operations through 2028.

Via Benzinga

CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates

May 20, 2025

Via ACCESS Newswire

CureVac Receives Additional Positive Validity Decision from European Patent Office in Ongoing Litigation Against BioNTech SE

May 15, 2025

Via ACCESS Newswire

CureVac Stock Declines On Weaker-Than-Expected Q4 Revenue: Retail’s On Wait-And-Watch Mode ↗

April 10, 2025

The company reported revenue of €14.5 million for the fourth quarter, representing a decrease of €8.1 million from the corresponding period of 2023, and below an analyst estimate of €20.58, according...

Via Stocktwits

Topics Government

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business Update

April 10, 2025

Via ACCESS Newswire

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.